Impfungen in der Pneumologie

Forstner, Christina; Pletz, Mathias W.

doi:10.1055/s-0034-1377412

Cited by 3 publications

(1 citation statement)

References 76 publications

(42 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…12 The use of the less efficient acellular pertussis vaccine and the waning immunity in older people has increased the necessity for regular booster vaccines. 13,14 Most HCWs were informed about their vaccination status concerning influenza, but only 42.1% decided to receive the vaccine. Especially young HCWs often declined the influenza vaccine with only 26.3% of the 20 to 29 y olds being vaccinated.…”

Section: Discussionmentioning

confidence: 99%

Knowledge, risk perception and attitudes toward vaccination among Austrian health care workers: A cross-sectional study

Harrison

Brand

Forstner

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

The aim of this study was to evaluate the vaccination coverage of Austrian health care workers (HCWs), their knowledge concerning the current guideline on vaccination for HCWs and their attitudes toward vaccination. A cross-sectional survey was performed by distributing 200 questionnaires among the nursing staff of several medical wards and intensive care units of the Vienna General Hospital. 116 questionnaires were returned for analysis with 77.4% female and 22.6% male participants. While certain vaccines like hepatitis B, tetanus and polio had high vaccination rates of up to 94% and good knowledge concerning the vaccination status, other vaccines like measles (59.8%), mumps (60.7%), rubella (70.5%), influenza (42.1%) or pertussis (58.2%) showed much lower coverage. The main sources of information were nursing school (59.1%), secondary school (46.1%), parents (45.2%) and media in general (45.2%). Only 21.9% of HCWs claimed to know the current guideline on vaccination. Those who knew the guideline were significantly more likely to consider certain vaccines like measles, mumps, rubella, diphtheria, polio and varicella as recommended (p 0.04). The most important reasons for receiving vaccination were selfprotection (87.5%), prevention of epidemics (54.5%), protection of others (55.4%) and of patients (42.9%). Fear of side effects (67.2%), negative experiences with vaccines (22.4%), the additional doctor's appointment (20.7%) and considering vaccines as an invention by the pharmaceutical industry (19%) were hindering factors for vaccination of HCWs. Considering the essential role of HCWs in preventing diseases, this study noted a remarkable lack of information on vaccination in this profession.

show abstract

Section: Discussionmentioning

confidence: 99%

Knowledge, risk perception and attitudes toward vaccination among Austrian health care workers: A cross-sectional study

Harrison

Brand

Forstner

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

Empfohlene Impfungen bei Lungenkranken

Thalhammer¹

2019

Pneumo News

View full text Add to dashboard Cite

Impfen bei pneumologischen Erkrankungen – was, wann und wie?

Kodde,

Sander

2024

Dtsch Med Wochenschr

View full text Add to dashboard Cite

Was ist neu? SARS-CoV-2 Im Zuge der COVID-19-Pandemie wurden erstmalig Impfstoffe zugelassen, die auf der mRNA-Technologie beruhen. Dabei kodiert die mRNA für das virale Spike-Protein und es kommt nach der Impfung zur Ausbildung von spezifischen Antikörpern und T-Zellen, welche einen sehr wirksamen Schutz gegen eine schwere Erkrankung und Tod infolge von COVID-19 bewirken. Aufgrund von genetischer Variabilität und rascher Evolution des SARS-CoV-2-Virus entstehen regelmäßig neue Virusvarianten. Die verfügbaren Impfstoffe können vergleichsweise schnell an die saisonal dominierenden Virusvarianten angepasst werden. Für die kommende Wintersaison werden mRNA-Impfstoffe gegen die SARS-CoV-2-Omicron-Sublinie JN.1 empfohlen. Saisonale Influenza Saisonale Influenzaviren verändern sich saisonal erheblich in ihren antigenen Eigenschaften, sodass jährlich veränderte Impfstoffe zur Auffrischung gegeben werden. Die WHO trifft jeweils im Frühjahr eine Vorhersage und spricht eine Empfehlung für die Hersteller aus, welche genetischen Hämagglutinin- und Neuraminidase-Varianten für den saisonalen Influenzaimpfstoff berücksichtigt werden sollen. Bislang wurden quadrivalente Impfstoffe empfohlen. Für die Saison 2024/2025 auf der Nordhalbkugel wurden trivalente Impfstoffe empfohlen, da seit 2020 die Influenza-B-/Yamagata-Linie nicht mehr zirkuliert. Für die Altersgruppe >60 Jahre ist ein Hochdosis-Impfstoff mit der 4-fachen Antigenmenge empfohlen, der in dieser Altersgruppe eine leichtgradig verbesserte Wirksamkeit zeigt.

show abstract

Impfungen in der Pneumologie

Cited by 3 publications

References 76 publications

Knowledge, risk perception and attitudes toward vaccination among Austrian health care workers: A cross-sectional study

Knowledge, risk perception and attitudes toward vaccination among Austrian health care workers: A cross-sectional study

Empfohlene Impfungen bei Lungenkranken

Impfen bei pneumologischen Erkrankungen – was, wann und wie?

Contact Info

Product

Resources

About